The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has been reaccredited for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. Also included is a new accreditation for immune effector cells.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
Philadelphia Media Outlets Cover Important Announcement Concerning Temple Health and Keystone First Family Health Plans
Posted July 10, 2024Temple Health’s (providers and hospitals) provider agreement with health insurance company Keystone First Family Health Plans is scheduled to end on July 31st.
Read MoreMoves in Medicine: Dr. Charles Bakhos and Patient Discuss Diaphragm Paralysis
Posted July 8, 20246ABC-TV and Temple Health collaborated on a sponsored segment about diaphragm paralysis. The segment featured Dr. Charles Bakhos and a patient.
Read More